Elucidating Complex Biology in the Immuno-Oncology Era
The Universal Cancer Immunogenomics Platform
A Single Platform. A Single Sample. Multiple Biomarkers.
Predictive & Prognostic
ImmunoID NeXT provides a multidimensional view of the tumor and the TME, empowering our partners to extract the most information from the least amount of sample.
Ready to streamline your precision oncology translational and clinical research programs?
- Biomarkers EU Congress, Manchester, UK | February 18-20
- Immuno-Oncology 360°, New York | February 26-28
- Precision: Colorectal Cancer Summit, San Francisco, CA | March 10-11
- NeoAG Summit EU 2020, Amsterdam, Netherlands | April 8-9
- AACR Annual Meeting, San Diego, CA | April 24-29